Pediatric Allergy Immunology and Pulmonary Medicine

A clinical trial supports approval of a new medication to treat moderate-to-severe asthma in children.

Study finds early RSV infection linked to significantly increased risk of asthma in children

A Vanderbilt study has found that RSV infection in the first year of life is associated with a significantly increased risk of asthma in children.

International study supports dupilumab for treatment of moderate-to-severe asthma in children

In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11 with moderate-to-severe asthma, offering a new option to these patients.

VUMC mourns loss of pediatric immunology expert Lawton

Alexander R. “Sandy” Lawton III, MD, emeritus professor of Pediatrics, died earlier this fall at 82.

Children’s Hospital launches pediatric food allergy clinic

Monroe Carell Jr. Children’s Hospital at Vanderbilt has launched a new pediatric food allergy clinic.

Conference explores facts of pediatric allergic diseases

Pediatric allergic diseases — food, drug, seasonal allergies — and anaphylaxis, a potentially life threatening allergic reaction, are on the rise and researchers are working furiously to understand, prevent and treat these conditions.

Pediatric Pulmonary Hypertension program lauded

Monroe Carell Jr. Children’s Hospital at Vanderbilt’s Pediatric Pulmonary Hypertension (PH) program has earned the top level of accreditation from the national Pulmonary Hypertension Association (PHA).